| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 241.76B | 233.86B | 175.45B | 391.06B | 333.69B | 171.26B |
| Gross Profit | 68.37B | 69.05B | 27.59B | 173.07B | 141.15B | 24.33B |
| EBITDA | 66.36B | 66.17B | 56.15B | 191.24B | 144.68B | 30.40B |
| Net Income | 49.77B | 49.10B | 23.86B | 109.79B | 89.35B | 9.93B |
Balance Sheet | ||||||
| Total Assets | 498.50B | 497.47B | 462.43B | 511.78B | 413.67B | 271.93B |
| Cash, Cash Equivalents and Short-Term Investments | 169.35B | 185.17B | 181.21B | 236.97B | 178.69B | 53.51B |
| Total Debt | 79.00B | 76.22B | 84.55B | 94.02B | 125.33B | 140.42B |
| Total Liabilities | 215.60B | 212.41B | 219.21B | 258.26B | 234.81B | 193.23B |
| Stockholders Equity | 232.06B | 234.67B | 196.12B | 200.38B | 133.09B | 43.91B |
Cash Flow | ||||||
| Free Cash Flow | 48.53B | 43.31B | 7.29B | 186.31B | 161.40B | 38.36B |
| Operating Cash Flow | 72.45B | 69.31B | 22.61B | 196.80B | 170.95B | 45.03B |
| Investing Cash Flow | -27.12B | -26.97B | -18.35B | -32.98B | -8.54B | -3.29B |
| Financing Cash Flow | -49.49B | -40.62B | -60.02B | -115.38B | -34.79B | -36.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$256.44B | 6.39 | 13.13% | 12.48% | 30.56% | 108.49% | |
82 Outperform | HK$93.20B | 7.76 | 48.55% | 9.80% | 37.68% | 127.44% | |
79 Outperform | HK$62.17B | 4.19 | 6.63% | 5.72% | 9.00% | -4.33% | |
74 Outperform | HK$136.81B | 5.59 | 9.13% | 4.76% | 4.90% | 6.33% | |
74 Outperform | HK$20.55B | 8.82 | 5.04% | 4.97% | 7.26% | 6.73% | |
71 Outperform | HK$91.46B | 7.02 | 11.33% | 12.81% | 28.91% | 150.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |